EUVIMEDEUVIMED entdecken
Scoping ReviewStudienprotokollOpen Access · CC BY 4.0

Remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy: Protocol for a scoping review

Shuang Tao, Xiaoying Li, Zhongyuan Zhou, Hongbo Zhang iD

PLOS One · 19.11.2026 · 21 (11) · e0363250

DOI: 10.1371/journal.pone.0363250 ↗

Kurz gefasst

Scoping Review in der Zeitschrift PLOS One, online erschienen am 19.11.2026. Verfasst von Shuang Tao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Painology, the Affiliated Shunde Hospital of Jinan University, Foshan City, People's Republic of China. Hauptthemen laut MEDLINE: Endoscopy, Gastrointestinal, Benzodiazepines, Hypnotics and Sedatives. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Foshan City Self-Funded Science and Technology Innovation Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastrointestinal (GI) endoscopy is one of the most commonly performed procedures in older adults, who constitute an increasing proportion of the endoscopic population yet face a higher risk of sedation-related cardiorespiratory adverse events, delayed recovery, and postoperative neurocognitive disturbances. Remimazolam, an ultra-short-acting benzodiazepine metabolised by tissue esterases independently of hepatic and renal function, is a candidate sedative of particular interest in this group. However, the extent and gaps of the available evidence specific to sedation with remimazolam in elderly patients undergoing GI endoscopy have not been systematically mapped.

Objectives

To systematically map the existing evidence on the use of remimazolam for procedural sedation in elderly patients (aged ≥65 years) undergoing GI endoscopy, characterising study design, reported outcomes, comparators, and dosing regimens, and identifying knowledge gaps.

Methods

This scoping review will be conducted in accordance with the JBI methodology for scoping reviews and reported following the PRISMA extension for Scoping Reviews (PRISMA-ScR). We will search PubMed, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and Scopus, together with the Chinese databases CNKI, Wanfang, and VIP (CQVIP), from 1 January 2015 to the search date—a start date that precedes the earliest published clinical reports of remimazolam. Google Scholar will be used as a supplementary source for grey literature and additional records. The search will be further supplemented by trial registries (ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform[ICTRP], and the Chinese Clinical Trial Registry[ChiCTR]), citation chasing, and additional grey literature. Eligibility will be limited to reports published in English or Chinese, reflecting the substantial body of relevant Chinese-language literature. Two reviewers will independently screen records and extract data using a piloted extraction form. Results will be presented in tabular and diagrammatic form alongside a narrative synthesis and an evidence map. Expected results and dissemination This scoping review is expected to map the current extent, range, and nature of evidence on remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy, will map the volume, designs and outcomes of existing studies and, by visualising this evidence, identify gaps to inform trial design in this high-risk population. The findings will be disseminated through publication in a peer-reviewed journal and presentation at relevant academic conferences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopy, GastrointestinalBenzodiazepinesHypnotics and SedativesHumansScoping Reviews as TopicAgedGeriatric Anesthesia

Substanzen

BenzodiazepinesHypnotics and Sedativesremimazolam

Autor:innen und Institutionen

  • Department of Painology, the Affiliated Shunde Hospital of Jinan University, Foshan City, People's Republic of China.
  • Department of Gastrointestinal Endoscopy, the Affiliated Shunde Hospital of Jinan University, Foshan City, People's Republic of China.

ORCID-Profile: Hongbo Zhang

Förderung

  • the Foshan City Self-Funded Science and Technology Innovation Projects

Zitieren

APA

Tao, S., Li, X., Zhou, Z., & Zhang, H. (2026). Remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy: Protocol for a scoping review. PLOS One, 21(11), e0363250. https://doi.org/10.1371/journal.pone.0363250

Vancouver

Tao S, Li X, Zhou Z, Zhang H. Remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy: Protocol for a scoping review. PLOS One. 2026;21(11):e0363250. doi:10.1371/journal.pone.0363250

BibTeX
@article{Tao2026,
  author = {Tao, Shuang and Li, Xiaoying and Zhou, Zhongyuan and Zhang, Hongbo},
  title = {Remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy: Protocol for a scoping review},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0363250},
  doi = {10.1371/journal.pone.0363250}
}
Kostenlos starten →